Posterior leukoencephalopathy after combination chemotherapy in a patient with lymphoma

Leukemia and Lymphoma

Volumn 46, Issue 12, 2005, Pages 1825-1828

  Abali, H ^a   Eren, O ^a   Dizdar, Ömer ^a   Karadag O ^a   Erman, M ^a   Yilmaz, A ^a   Uluc K ^a   Erdem, I ^b   Turker A ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Etoposide; Idarubicin; Ifosfamide; Methotrexate; Posterior leukoencephalopathy syndrome; T cell lymphoma

Indexed keywords

ALLOPURINOL; CISPLATIN; CONTRAST MEDIUM; CREATININE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; GLYCERYL TRINITRATE; IDARUBICIN; IFOSFAMIDE; MESNA; METHOTREXATE; PRIMIDONE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DEATH; DISORIENTATION; DRUG DOSE REDUCTION; EPISTAXIS; FEMALE; FOLLOW UP; GRAND MAL SEIZURE; HALLUCINATION; HEMODIALYSIS; HUMAN; HYPERTENSION; INTRACTABLE EPILEPSY; LEUKOENCEPHALOPATHY; LYMPHADENOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SALVAGE THERAPY; SORE THROAT; T CELL LYMPHOMA; TONIC CLONIC SEIZURE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; ETOPOSIDE; FATAL OUTCOME; FEMALE; HEMOGLOBINS; HUMANS; IDARUBICIN; IFOSFAMIDE; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOMA; MAGNETIC RESONANCE IMAGING;

EID: 32144443280     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500234424     Document Type: Article

References (10)

1. Haskell, C and Rosen, L.(2001) Antineoplastic agents. In Cancer Treatment. 5th ed. (pp. 104 - 214). Philadelphia: W.B. Saunders Inc.
2. Hinchey, J and Chaves, C and Appignani, B and Breen, J and Pao, L and Wang, A and (1996) A reversible posterior leukoencephalopathy syndrome N Engl J Med, 334, pp. 494 - 500.
3. Honkaniemi, J and Kähärä, V and Dastidar, P and Latvala, M and Hietaharju, A and Salonen, T and (2000) Reversible posterior leukoencephalopathy after combination chemotherapy Neuroradiology, 42, pp. 895 - 899.
4. King, P and Perry, M. (2001) Hepatotoxicity of chemotherapy The Oncologist, 6, pp. 162 - 176.
5. Dillon, W and Rowley, H. (1998) The reversible posterior cerebral edema syndrome Am J Neuroradiol, 19, pp. 591.
6. Tam, C and Galanos, J and Seymour, J and Pitman, A and Stark, R and Prince, H. (2004) Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies Am J Hematol, 77, pp. 72 - 76.
7. Ay, H and Buonanno, F and Schaefer, P and Le, D and Wang, B and Gonzales, R and Koroshetz, W. (1998) Posterior leukoencephalopathy without severe hypertension utility of diffusion-weighted MRI Neurology, 51, pp. 1369 - 1376.
8. Pas, T and Curigliano, G and Catania, C and Comandone, A and Braud, F. (2000) Ifosfamide in the elderly: Clinical considerations for a better drug management Oncol Hematol, 33, pp. 129 - 135.
9. Carlson, L and Goren, M and Bush, D and Griener, J and Quigley, R and Tkaczewski, I and (1998) Toxicity, pharmacokinetics, and in vitro hemodialysis clearance of ifosfamide and metabolites in an anephric pediatric patient with Wilm's tumor Cancer Chem Pharm, 41, pp. 140 - 146.
10. Shin, R and Stern, J and Janss, A and Hunter, J and Liu, G. (2001) Reversible posterior leukoencephalopathy during the treatment of acute lymphoblastic leukemia Neurology, 56, pp. 388 - 391.